Docetaxel

“Docetaxel will be administered as an IV dose of 75 milligrams per square meter (mg/m\^2) on day 1 of cycle 1 (1 cycle length = 21 days), and 75 mg/m\^2 (up to 100 mg/m\^2 as...” NCT03811418 ↗

“Any of the following single-agent chemotherapy may be given at the discretion of the investigator, with a cycle length not to exceed four weeks: Capecitabine, Vinorelbine,...” NCT01156753 ↗

“Patients receive Neoadjuvant Docetaxel (75mg/m2 on day1 03:30-04:30) and cisplatin (75mg/m2 on day 1-5 10:00-22:00) and 5-FU(750mg/m2 on day 1-5 22:00-10:00) every 21days for...” NCT03604965 ↗

“Squamous cell carcinoma: Paclitaxel (175mg/m²) or Docetaxel (60-75 mg/m²) or Nab-paclitaxel (260mg/m²) plus Carboplatin (AUC=5)/Cisplatin (75 mg/m²) (to be determined by...” NCT07608159 ↗

“An Open-label, Randomized Study to Evaluate the Effect of Tarceva, Compared With Alimta (Pemetrexed) or Taxotere (Docetaxel),on Survival in Patients With Advanced, Recurrent or...” NCT00556322 ↗

“Acceptable histology-specific PDC regimens include carboplatin plus paclitaxel or nab-paclitaxel (any histology), carboplatin/cisplatin plus pemetrexed (nonsquamous),...” NCT06865339 ↗

“A1: docetaxel 60mg/m2 on Day 1 vinorelbine 20mg/m2 on Day 1 and Day 8 (DV) A2: gemcitabine 1000mg/m2 on Day 1 vinorelbine 25mg/m2 on Day 1 and Day 8 (GV) A3: docetaxel 75mg/m2...” NCT01648517 ↗

“Docetaxel 75 mg/m2, day 1 Epirubicin 80 mg/m2, day 1 Cyclophosphamide 500 mg/m2, day 1 Navelbine 25 mg/M2 in 250 cc NS over 60 min on day 1 and day 8 Bevacizumab 5 mg/kg in 100...” NCT00830544 ↗

“The Pharmacy of The Netherlands Cancer Institute has developed a new oral formulation of docetaxel (ModraDoc006), which contains a spray dried docetaxel powder resulting in an...” NCT05242926 ↗

“This study was designed to evaluate the efficacy and safety of combined zoledronic acid and docetaxel/carboplatin in patients with non-small cell lung cancer (NSCLC) as...” PMID 19493585 ↗ Jun 2009

“Epirubicin (90 mg/m², intravenous infusion) combined with cyclophosphamide (600 mg/m², intravenous infusion, every 2 weeks or 3 weeks, determined by investigators) for 4...” NCT07410559 ↗

“Docetaxel (currently marketed as Taxotere®) is an anti-microtubule agent that prevents cell division by promoting the assembly and stabilization of microtubules and is used for...” NCT01151384 ↗

“four cycles of docetaxel and cyclophosphamide or four cycles of weekly paclitaxel Combined with Trastuzumab followed by standard endocrine therapy( aromatase inhibitors or...” NCT07213206 ↗

“Study treatment in the arm A is left to the investigator appreciations. This may include immune checkpoint inhibitors, docetaxel, topotecan for primary lung tumors, and FOLFOX,...” NCT06937905 ↗

“Participants enrolled will receive QL1706 (5 mg/kg, Q3W, d1) + docetaxel (50 mg/m², Q3W, d1) + oxaliplatin (100 mg/m², Q3W, d1) + leucovorin (LV) (400 mg/m², Q3W, d1) +...” NCT07400315 ↗

“Patients received neoadjuvant Camrelizumab 200mg combined with chemotherapy (Cisplatin 20mg/m2, Day 1-3, Docetaxel 75mg/m2, Day 1) for 2 cycles every 21 days, followed by...” NCT04782765 ↗

“Control chemotherapy treatment will be chosen from any of the following standard-of-care chemotherapy drugs or combinations: * Liposomal Doxorubicin; * Docetaxel; *...” NCT03949283 ↗

“A Randomized Cost-minimization Trial Comparing Pemetrexed (Alimta®) Versus Docetaxel (Taxotere®) as Second Line Treatment in Advanced Non Small Cell Lung Cancer (NSCLC): Study...” NCT00284778 ↗

“A Phase 1 Open Label, Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Given by Intravenous...” NCT01300533 ↗

“Patients will receive neoadjuvant therapy consisting of 4 cycles of avelumab added to the modified chemotherapy regimen of docetaxel, cisplatin, 5-fluorouracil (mDCF), followed...” NCT03288350 ↗

“Chemotherapy agents may include doxorubicin, ifosfamide, docetaxel, CHOP regimen, etoposide, cyclophosphamide and vincristine which will be administered as per standard of care...” NCT04570423 ↗

“Carboplatin, cisplatin, paclitaxel, docetaxel, gemcitabine, vinorelbine, pemetrexed, or erlotinib administered on Day 1 of every 21-day cycle except gemcitabine, which was...” NCT00312728 ↗

“The purpose of this clinical trial is to evaluate the efficacy and safety of Fluzoparib combined with docetaxel in sequential paclitaxel combined with cyclophosphamide for...” NCT07162051 ↗

“The chemotherapy regimen consisting of doxorubicin 60 mg/square meter (m\^2) and docetaxel 75 mg/m\^2 will be administered sequentially by intravenous (IV) infusion on Day 1 of...” NCT00837265 ↗

“Doxorubicin (Adriamycin) + cyclophosphamide (Cytoxan) with pegfilgrastim or filgrastim growth factor support every 2 weeks for 4 cycles, followed by docetaxel + lapatinib for...” NCT00404066 ↗

“Concurrently, patients will receive docetaxel (20 mg/m2) IV weekly (Monday) and 5-fluorouracil (300 mg/m2) as a 24 hour continuous infusion for 5 of 7 days (Monday-Friday) of...” NCT00561197 ↗

“In the University Hospital Center of Besançon, 8 patients with metastatic anal cancer were treated between 2005 and 2008 by 6 cycles of chemotherapy including taxane: DCF...” NCT01845779 ↗

“mDOF(docetaxel 50 mg/ m2 day 1 + oxaliplatin 85 mg/ m2 day 2 + fluorouracil 400 mg/ m2 bolus iv followed by 600 mg/ m2 22 hours chronic infusion, day 2/3 + leucovorin 200 mg/...” NCT02960061 ↗

“Patients received two 21-day courses of induction CTx of TS-1 (35 mg/m2, p.o, twice daily on days 1-14), docetaxel (30 mg/m2, i.v., days 1 and 8), and cisplatin (30 mg/m2,...” PMID 31302344 ↗ Jul 2019

“Drug: Taxane chemotherapy Docetaxel, 75mg/m², D1, Q3W, iv drip, maximum 6 cycles; or paclitaxel, 175mg/m², D1, Q3W, iv drip, maximum 6 cycles; or nab-paclitaxel, 260mg/m², D1,...” NCT07581821 ↗

“CONCLUSION: Docetaxel anhydrous CKD-810 use with patients suffering advanced or metastatic solid malignancies was equivalent to reference docetaxel in terms of pharmacokinetic...” PMID 24337589 ↗ Dec 2013

“Following this, a period of one to two weeks was to elapse before the initiation of Tislelizumab (200 mg), Docetaxel (75 mg/m²), and Cisplatin (75 mg/m²), on a three-week...” NCT07402538 ↗

“Current systemic therapy is most commonly a second generation androgen pathway inhibitor, including enzalutamide or abiraterone, although other standard agents (e.g. docetaxel,...” NCT03556904 ↗

“Chemo+Far: paclitaxel 175 mg/m2 (or docetaxel, 75 mg/m2) plus carboplatin area under the concentration-time curve (AUC) 5-6 intravenously (IV) on Day 1 of a 21-day cycle plus...” NCT00318370 ↗

“A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal...” PMID 23406728 ↗ Feb 2013

“Bridging therapy including Anti-AR agents (example, abiraterone, enzalutamide) will be administered orally and radiotherapy, or chemotherapy (example, docetaxel) will be...” NCT05022849 ↗

“Docetaxel/paclitaxel/albumin paclitaxel/liposomal paclitaxel, dosage and administration are determined according to the latest version of the NCCN and CSCO breast cancer...” NCT06278870 ↗

“The patient with response or stable disease will receive maintenance therapy with one or some of the drugs including bevacizumab, pemetrexed, gemcitabine and docetaxel until...” NCT02701231 ↗

“The other drug must contain one of the following: etoposide, vinorelbine, vinblastine, pemetrexed, taxanes (e.g., paclitaxel, docetaxel, albumin paclitaxel, paclitaxel...” NCT06424899 ↗

“Chemotherapy will consist of docetaxel, paclitaxel, or capecitabine, as determined by the investigator, and will be administered per the respective package insert and...” NCT04632992 ↗

“Taxanes (paclitaxel, docetaxel, liposomal paclitaxel, nabpaclitaxel), vinorelbine, capecitabine, eribulin, and other chemotherapeutic agents indicated in advanced breast cancer...” NCT05621434 ↗

“Patients with squamous cell carcinoma received docetaxel administered in 3-week cycles, and patients with adenocarcinoma received pemetrexed, patinum and one of sintilimab or...” NCT07076693 ↗

“Docetaxel 60mg/m2 and Cisplatin 70 mg/m3 3 weekly regimen will be compared to Pemetrexed 500mg/m2 and Cisplatin 70 mg/m2 3 weekly regimen in first line NSCLC with non-squamous...” NCT01282151 ↗

“4 injections of doxorubicin (60 mg/m²) combined with cyclophosphamide (600 mg/m²) every 3 weeks (+/- 2 days), followed by 4 injections of docetaxel (100 mg/m²) every 3 weeks...” NCT01367288 ↗

“The starting dose of Taxotere® (docetaxel) will be 75 mg/m2 administered intravenously over 60 minutes every three weeks on Day 1 of each cycle (i.e., every 21 days), maximum 6 cycles.” NCT02187744 ↗

“One of the following Treatment of Physician Choice will be administered per standard of care: eribulin, ixabepilone, vinorelbine, gemcitabine, paclitaxel, docetaxel, or nab-paclitaxel” NCT01492101 ↗

“Physician's Choice of carboplatin (preferred) or cisplatin，gemcitabine, taxane (paclitaxel, docetaxel or nab-paclitaxel) or pegylated liposomal doxorubicin，with or without bevacizumab.” NCT05684731 ↗

“Docetaxel is a standard second-line treatment offered to patients with non-small-cell lung cancer who haven't responded to first-line therapies (platinum-based drugs or radiotherapy).” NCT00097851 ↗

“Investigator-selected chemotherapy includes injectable taxanes (paclitaxel injection, albumin-bound paclitaxel, docetaxel, etc.), irinotecan, etc., excluding oral paclitaxel solution.” NCT07552402 ↗

“OBJECTIVES: * Compare, by intention to treat analysis, feasibility and efficacy of 4 courses of docetaxel, cisplatin, and fluorouracil as preoperative or postoperative chemotherapy” NCT00005060 ↗

“The purpose of this trial is to test the combination of Gleevec® (also known as imatinib mesylate) and Taxotere (also known as docetaxel) in patients with incurable stomach cancer.” NCT00209079 ↗

“Androgen deprivation with or without docetaxel chemotherapy, Abiraterone, Enzalutamide or any other proven agent) treatment as determined by treating physician (positive control).” NCT03763253 ↗

“Chemotherapy (nab-paclitaxel, pemetrexed, or docetaxel) Nab-paclitaxel, also known as nanoparticle albumin-bound paclitaxel, is a chemotherapy drug used to treat certain cancers.” NCT07134413 ↗

“Induction chemotherapy (ICT) with docetaxel, cisplatin and fluorouracil (TPF) followed by radiotherapy is an effective treatment option for locally advanced head and neck cancer.” PMID 28498880 ↗ Aug 2017

“six 3-weekly cycles of intravenous paclitaxel [175 mg/m2] or docetaxel [75 mg/m2] combined with intravenous carboplatin [area under the curve of 5 mg/mL per min]; surgery group)” PMID 33705695 ↗ Mar 2021

“Doxorubicin 60mg/m2 and cyclophosphamide 600mg/m2 (AC) every 21 days for 4 cycles followed by weekly paclitaxel 80mg/m2 for 12 weeks or 3-weekly docetaxel 100mg/m2 for 4 cycles.” NCT04293393 ↗

“Chemotherapy：Vincristine/paclitaxel/docetaxel/pemetrexed/gemcitabine plus cisplatin/carboplatin：administrated for patients with NSCLC requiring post-operative adjuvant therapy.” NCT05834413 ↗

“The administration of chemotherapy regimen (docetaxel or irinotecan) will be determined at the discretion of investigator, and depends on the patient's previous chemotherapy.” NCT00821990 ↗

“the following regimens may be selected as monotherapy or combination: docetaxel 60-75 mg/m2d1 q3w; irinotecan 150-180 mg/m2 d1 q2w until disease progression or patient death” NCT03787251 ↗

“Patients will be treated with six cycles of neoadjuvant chemotherapy combining epirubicin (75 mg/m² on day 1) and docetaxel (75 mg/m² on day 1), administered every 21 days” NCT00462696 ↗

“Docetaxel 50 mg/m² IV over 1 hour plus Oxaliplatin 85 mg/m² IV over 2 hours plus Folinic Acid 200 mg/m² IV over 1 hour plus 5-FU 2600 mg/m² IV over 24 hours every 2 weeks” NCT05504720 ↗

“Additional therapy following tumor board meeting : new generation hormonal therapy (abiraterone, enzalutamide, apalutamide or other approved) or chemotherapy (docetaxel).” NCT04115007 ↗

“Chemotherapy regimen will be at the discretion of the treating physician, and may consist of docetaxel or cabazitaxel with or without a platinum agent (e.g. carboplatin).” NCT03248570 ↗

“Induction chemotherapy consisted of three cycles of docetaxel (75 mg/m², day 1), cisplatin (75 mg/m², day 1), and penpulimab (200 mg, day 1), administered every 3 weeks.” NCT07392320 ↗

“Chemotherapy was comprised of docetaxel 30 mg/m2 on days 1 and 8, cisplatin 60 mg/m2 on day 1, and S-1 70 mg/m2 on days 1 to 14, with the regimen repeated every 21 days” NCT01645748 ↗

“The trial doctor will select either an ARPI of enzalutamide or abiraterone, or a taxane based chemotherapy of docetaxel or cabazitaxel or \[177Lu\]Lu-PSMA-617 (AAA617).” NCT06855277 ↗

“All subjects on both phases of the study will be concurrently treated with a taxane regimen containing either paclitaxel given weekly or docetaxel given every 3 weeks.” NCT03611985 ↗

“The FLOT regimen consisted of four cycles of 5-Fluorouracil 2600 mg/m2, Leucovorin 200 mg/m2, Oxaliplatin 85 mg/m2, and Docetaxel 50 mg/m2, intravenous every 2 weeks.” PMID 41181842 ↗ Oct 2025

“recurrent treatment was docetaxel 75 mg/m2 intravenously on day 1 plus prophylactic granulocyte-colony stimulating factor 6 mg subcutaneously on day 4 every 21 days.” PMID 41212474 ↗ Nov 2025

“Perioperative FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) is a standard therapy for resectable gastric and gastroesophageal junction adenocarcinomas” PMID 40454643 ↗ Jun 2025

“INDUCTION CTx(TPF):docetaxel 75 mg/m² + CDDP 80mg/m² + 5-FU 800 mg/m²/day from day 1 to day 4 will begin after the end of cisplatin infusion on day 1.Every 3 weeks.” NCT01086826 ↗

“Induction chemotherapy TP regimen combined with Tislelizumab for 3 cycles: Cisplatin 37.5mg/m2 d1-2 q3w, Docetaxel 37.5mg/m2 d1and d3 q3w,Tislelizumab 200mg d3 q3w.” NCT06554028 ↗

“ModraDoc006 is a novel docetaxel tablet formulation that is co-administrated with the cytochrome P450 3A4 and P-glycoprotein inhibitor ritonavir (r): ModraDoc006/r.” PMID 33464545 ↗ Jan 2021

“All patients received weekly docetaxel(25mg/㎡) and nedaplatin or cisplatin (25mg/㎡), each of 1 day's duration, concurrently with hypofractionated radiotherapy .” NCT03663764 ↗

“chemotherapy, single agent including docetaxel, albumin-bound paclitaxel, vinorelbine, gemcitabine, pemetrexed, or paclitaxel, as determined by the investigator” NCT01850147 ↗

“neoadjuvant chemoimmunotherapy of Sindilizumab (200mg) plus docetaxel (75mg/m2) and cisplatin (75mg/m2) will be administered every three weeks for three cycles.” NCT06219980 ↗

“paclitaxel or albuminotaxol or docetaxel combined with platinum, pemetrexed combined with platinum. Platinums include carboplatin, cisplatin and nedaplatin.” NCT06775275 ↗

“Docetaxel 60mg/m2, intravenous infusion, day 1; Capecitabine 1000mg/m2, oral administration, twice a day, day1-14; 3 weeks a cycle for 8 consecutive cycles.” NCT01618474 ↗

“Chemotherapy as taxane (docetaxel or paclitaxel) or vinflunine administered through intravenous (i.v.) infusion every 3 weeks (on day 1 of a 21-day cycle)” NCT03410693 ↗

“TP regimen: Docetaxel 75 mg/m2, intravenous infusion, D1， Cisplatin 75 mg/m2, intravenous infusion, D1， Every three weeks, there are two cycles in total.” NCT07055841 ↗

“Patients will receive oral docetaxel (as ModraDoc006 10 mg tablets) and ritonavir (100 mg tablet) once- or bi-daily, once a week in a fasted condition.” NCT03150368 ↗

“FEC-D (5-FU 500 mg/m2 plus epirubicin 100 mg/m2 plus cyclophosphamide 500 mg/m2 q3weeks x 3 cycles followed by docetaxel 100 mg/m2 q3weeks x 3 cycles)” NCT02688803 ↗

“Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)” NCT00373204 ↗

“Lapatinib in combination with paclitaxel, letrozole, capecitabine, capecitabine/oxaliplatin, gemcitabine, docetaxel, trastuzumab, FOLFOX4, or FOLFIRI” NCT00790816 ↗

“The chemotherapy treament：docetaxel( 75mg/m2/d,every21days,for4\~6cycles) and cisplatin(total dose 75mg/m2 on day 2,3,4,every21days,for4\~6cycles).” NCT00985998 ↗

“Induction intravenous docetaxel every 3 weeks or paclitaxel every week could be administered for 18 to 24 weeks at the investigator's discretion” PMID 30106636 ↗ Aug 2018

“Standard chemotherapy of physician's choice (capecitabine, docetaxel, nab paclitaxel, or paclitaxel), administered according to product label.” NCT04031885 ↗

“Agents of interest included Abiraterone, Enzalutamide, Pembrolizumab, Ipilimumab, Carboplatin, Docetaxel, and Olaparib as well as combinations” NCT04399876 ↗

“Adenosine Triphosphate Tumor Chemosensitivity(Oxaliplatin, Gemcitabine, Irinotecan, Paclitaxel,docetaxel, Fluorouracil,Doxorubicin,Cisplatin)” NCT02580253 ↗

“Docetaxel 50mg/m2, ivgtt, d1; Oxaliplatin 85 mg/m2, ivgtt, d1; Calcium folinate 200mg/m2, ivgtt, d1; 5-fluorouracil 2600mg/m2, 24h civ, d1,” NCT05610332 ↗

“docetaxel (T) 75 mg/m2, cisplatin (P) 75 mg/m2, 5-Fluorouracil (F) 750 mg/m2 through intravenous infusion each 3-week cycle for 2 cycles.” NCT04649476 ↗

“TCH-P Taxotere (docetaxel), Carboplatin, Herceptin (trastuzumab), Perjeta (pertuzumab) standard of care neoadjuvant chemotherapy regimen” NCT03387553 ↗

“Treatment with weekly ModraDoc006 (oral docetaxel) 10mg tablets in combination with ritonavir 100mg tablets in fed or fasting condition” NCT05084456 ↗

“Possible platinum doublet chemotherapy regimens are Cisplatin/Carboplatin in combination with Pemetrexed or Docetaxel or Gemcitabine.” NCT06902272 ↗

“Paclitaxel 80 mg/m² IV weekly or docetaxel 75 mg/m² IV every 21 days until disease progression, unacceptable toxicity, or withdrawal” NCT07528768 ↗

“Docetaxel 36 mg/m2 intravenous infusion over 1 hr, followed by Cisplatin 30 mg/m2 intravenous infusion over 1 hr, on day 1 and day 8” NCT03161548 ↗

“Patients received a weekly infusion of docetaxel (25 mg/m2) and cisplatin (25 mg/m2) concurrent with hypo-RT and hypo-boost therapy.” NCT04212052 ↗

“Treatment with twice daily once weekly (BIDW) ModraDoc006 (oral docetaxel) 10mg tablets in combination with ritonavir 100mg tablets” NCT03890744 ↗

“Docetaxel（75 mg/m² ）or paclitaxel（175 mg/mg） plus carboplatin (AUC5) or cisplatin（75 mg/m²）on Day 1 of 21day cycles (every 3 weeks)” NCT07063329 ↗

“followed by docetaxel (at a dose of 75 mg per square meter of body-surface area) was administered as a 1-hour intravenous infusion” NCT01425736 ↗

“SGT-53 (2.4 mg DNA per infusion) will be administered in combination with docetaxel at 40 mg/m2 starting dose, cohort 1, cycle 1.” NCT00470613 ↗

“Standard taxane (docetaxel 75 mg/m\^2 IV every 3 weeks or paclitaxel 80 mg/m\^2) IV once a week according to investigator choice.” NCT01641939 ↗

“physician choice: taxane-based chemotherapy to include Paclitaxel, Docetaxel, Abraxane or Ixabepilone given as standard of care” NCT02067416 ↗

“Phase II Study of Neoadjuvant Adebrelimab, Docetaxel, Oxaliplatin, and S-1 in Patients With Resectable Advanced Gastric Cancer” NCT06475417 ↗

“A PHASE II STUDY OF THE CLINICAL AND BIOLOGIC EFFECTS OF DOCETAXEL (TAXOTERE) IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER” NCT00206505 ↗

“Methotrexate, Paclitaxel, Docetaxel, Carboplatin, 5-Fluorouracil, Bleomycine, Gemcitabine, Mitomycine or Best supportive care” NCT03088059 ↗

“Docetaxel is a taxane chemotherapy which has been shown to prolong survival in men with castration resistant prostate cancer.” NCT05156905 ↗

“Docetaxel 75 mg/m2, Cyclophosphamide 600 mg/m2 and Trastuzumab 8 mg/kg followed by 6 mg/kg Day 1 every 21 days for 4 cycles.” NCT03705429 ↗

“50 mg/m² docetaxel, 85 mg/m² oxaliplatin, 200 mg/m² calcium folinate and 2600 mg/m² fluorouracil as 24 h-infusion, 2 cycles” NCT05713838 ↗

“chemotherapy may be a)gemcitabine/cisplatin, b)vinorelbine + cisplatin/docetaxel + cisplatin or c)vinorelbine or docetaxel” NCT00642824 ↗

“Pyrotinib combined with docetaxel, carboplatin and trastuzumab (TCbHPy) for neoadjuvant therapy of HR+/HER2+ breast cancer” NCT05430347 ↗

“Paclitaxel：Docetaxel 75mg/m2, albumin paclitaxel 260mg/m2, or paclitaxel liposomes 175mg/m2) is administered intravenously” NCT06578299 ↗

“IINJ DOCETAXEL 75mg/M2 in 500 ML NORMAL SALINE(PVC free container/glass bottle) via codon filter OVER 60 MIN (DAY 1 ONLY)” NCT06737822 ↗

“8 cycles of mDCF (docetaxel 40 mg/m2 day 1, cisplatin 40 mg/m2 day 1 and 5-FU at 1200 mg/m2/day for 2 days) every 2 weeks” NCT03519295 ↗

“G-FLIP-DM is low doses of Gemcitabine, Fluorouracil [5FU], Leucovorin, Irinotecan, Oxaliplatin, Docetaxel and Mitomycin C” NCT01905150 ↗

“Perioperative docetaxel 50mg/m2；oxaliplatin 85 mg/m2; 5Fu 2.4g/m2 civ 48 hours; repeated every 2 weeks; total of 8 cycles” NCT03961841 ↗

“chemotherapy (Squamous cell carcinoma selective platinum + docetaxel and Adenocarcinoma selective platinum + Pemetrexed)” NCT04958993 ↗

“Docetaxel plus cyclophosphamide (TC) for 4-6 cycles, administered per USPI (Unites States Prescribing Information) Label” NCT05256745 ↗

“Pembrolizumab (200 mg) plus chemotherapy (physicians' choice among docetaxel, pemetrexed, or vinorelbine) every 3 weeks” NCT03656094 ↗

“Albumin-bound paclitaxel 180 mg/m² (or docetaxel 75 mg/m²), administered on day 3, every 3 weeks (Q3W);for two cycles。” NCT07601737 ↗

“intraperitoneal perfusion with Docetaxel Polymeric Micelles (SIM0388) for injection in patients with malignant ascites” NCT07007988 ↗

“All patients will receive standard chemotherapy: cisplatin 50-60mg/m2 + fluorouracil 750 mg/m2 + docetaxel 60-80 mg/m2” NCT01829178 ↗

“subsequently followed by 3 cycles of Docetaxel 75 mg/m² body surface area i.v. (Doc), and Gemcitabine 1000 mg/m² i.v.” NCT02181101 ↗

“Patients will receive three q 21-day cycles of gemcitabine 1000 mg/m2 plus docetaxel 75 mg/m2 plus toripalimab 240 mg” NCT06592599 ↗

“The chemotherapy regimen for this trial consists of doxorubicin 60 mg/m\^2 and docetaxel 75 mg/m\^2 in combination” NCT01126190 ↗

“patients will receive standard doses of IV carboplatin and docetaxel for 2 treatment cycles with a 3 week interval” NCT00473954 ↗

“Neoadjuvant TPF chemotherapy (docetaxel 75 mg/m2, cisplatin 75 mg/m2, 5-FU 2500 mg/m2 every 3 weeks for 3 cycles)” NCT02012062 ↗

“Goserelin (3.75mg, once every 4 weeks)+Docetaxel (75 mg/m2 on day 1 every 3 weeks)+Prednisone (5 mg, twice daily)” NCT03696186 ↗

“neoadjuvant chemotherapy (docetaxel, oxaliplatin and fluorouracil/leucovorin) plus avelumab previous to surgery.” NCT03979131 ↗

“Docetaxel will be administered once every 3 weeks as an intravenous (IV) infusion (60 or 75 mg/m2) over 1 hour.” NCT01400555 ↗

“Neoadjuvant Chemotherapy with * Toripalimab + Cisplatin + Docetaxel OR * Toripalimab + Carboplatin + Docetaxel” NCT07209189 ↗

“Docetaxel was the first drug that showed survival benefits when added to the CF regimen, but it was very toxic.” NCT01283217 ↗

“Concurrent chemotherapy consists of weekly docetaxel(25mg/㎡) and nedaplatin(25mg/㎡), each of 1 day's duration.” NCT03659578 ↗

“Docetaxel: 70mg/m², intravenous infusion, on day 1, every 3 weeks (Q3W), for 3 cycles of neoadjuvant treatment” NCT06952621 ↗

“Concurrent chemotherapy consists of weekly docetaxel(25mg/㎡) and nedaplatin(25mg/㎡), each of 1 day's duration.” NCT03900117 ↗

“Concurrent chemotherapy consists of weekly docetaxel(25mg/㎡) and nedaplatin(25mg/㎡), each of 1 day's duration.” NCT02573506 ↗

“Docetaxel plus cisplatin chemotherapy regimen was delivered as chemotherapy and concurrent chemoradiotherapy.” NCT01889303 ↗

“gemcitabine 900 mg/m\^2 over 90 min on Day 1, and gemcitabine 900 mg/m\^2 and docetaxel 75 mg/m\^2 on Day 8.” NCT03742193 ↗

“For centrally located recurrent tumors, concurrent chemotherapy consists of weekly docetaxel and nedaplatin.” NCT04275687 ↗

“PEG-ENDO 1 mg/kg or 2 mg/kg or 4 mg/kg or 6 mg/kg or 8 mg/kg+Docetaxel 75 mg/m2，once every 3 weeks at day 1” NCT04413227 ↗

“Triplet or doublet therapy (ie. docetaxel/abiraterone, apalutamide，Rezvilutamide，darolutamide，enzalutamide)” NCT06350825 ↗

“14 days later IV: paclitaxel 175mg/m2 plus carboplatin AUC 5 or docetaxel 60-75mg/m2 plus carboplatin AUC 5” NCT01669226 ↗

“Induction chemotherapy: TP( Docetaxel 75mg/m2, D1 and cisplatin 25 mg/m2, D1-3 every 3 weeks for 3 cycles)” NCT05622474 ↗

“The regimen consists of docetaxel, 50 mg/m2, 5-FU, 2400 mg/m2, and leucovorin, 240 mg/m2 on days 1 and 15.” NCT00270543 ↗

“Monochemotherapy (containing one of the following): docetaxel, paclitaxel, vinorelbine, capecitabine, NPLD” NCT01619111 ↗

“Docetaxel: 75mg/m2, d1, q3w\*6, Epirubicin 75mg/m2, d1, q3w\*6 and Cyclophosphamide: 500mg/m2, d1, q3w\*6” NCT02532400 ↗

“docetaxel 50 mg/m², oxaliplatin 85 mg/m², leucovorin 200 mg/m² and 5-FU 2600 mg/m², all i.v. on day 1 Q2W” NCT07059299 ↗

“A taxane-based chemotherapeutic agent (e.g., paclitaxel or docetaxel) will be administered intravenously.” NCT06843681 ↗

“FLOT (5-FU, leucovorin, oxaliplatin, and docetaxel) Chemotherapy will be administered as an IV infusion.” NCT07069712 ↗

“T: docetaxel, nab-paclitaxel or paclitaxel. Routine clinical dosage and administration shall be adopted.” NCT07410234 ↗

“may include combinations of agents such as fluoropyrimidines and oxaliplatin with or without docetaxel.” NCT06942663 ↗

“Name/Substance: Docetaxel Formulation: Liquid (20 mg/2 ml) Dose: 75 mg/m\^2 Route: Intravenous infusion” NCT01440270 ↗

“Docetaxel (at a dose of 75mg/m2 of body surface area) was administered as a 2-hour intravenous infusion” NCT01542931 ↗

“Weekly bavituximab infusion of 3 mg/kg combined with up to six 28-day cycles of docetaxel chemotherapy.” NCT00669591 ↗

“FDA approved drugs for the study population: Bevacizumab, Docetaxel, Erlotinib, Gemcitabine, Pemetrexed” NCT02045446 ↗

“Docetaxel 75-100 mg/m2 IV day 1 and Cyclophosphamide 600-830 mg/m2 day 1 every 21 days for 4-6 cycles.” NCT05296746 ↗

“docetaxel(at a dose of 75mg/m2 of body surface area) was administered as a 2-hour intravenous infusion” NCT02285530 ↗

“docetaxel(at a dose of 75mg/m2 of body surface area) was administered as a 2-hour intravenous infusion” NCT02285543 ↗

“Docetaxel 75mg/m2+ Carboplatin AUC5 by intravenous (IV) infusion on day1, every 3 weeks, for 4 cycles.” NCT05843292 ↗

“These drugs include Cisplatin or Oxaliplatin and 5-fluorouracil (5 FU) in combination with Docetaxel.” NCT04931420 ↗

“docetaxel 40 mg/m2 on day 1, cisplatin 40 mg/m2 on day 1, and fluorouracil 1200 mg/m2 on days 1 and 2” PMID 41202834 ↗ Nov 2025

“docetaxel: 75 mg/m2, intravenous drip, d1 every three weeks for a cycle, a total of dosing 2 cycles;” NCT04766827 ↗

“Combination drugs : docetaxel (T), cisplatin (P), 5 Fluorouracil (F) and pembrolizumab every 21 days” NCT03114280 ↗

“Docetaxel 75 mg / m2 was administered on day 1 repeated every 21 days until progressive Disease(PD)” NCT03193424 ↗

“ADT with docetaxelᵇ plus an ARSI (i.e. abiraterone + prednisone, or darolutamide,) ± radiotherapyª” NCT06496581 ↗

“TC for stage I: Docetaxel 75 mg/m + Cyclophosphamide 600 mg/m, cycled every 21 days for 4 cycles.” NCT02464774 ↗

“The HIPEC regimens are Docetaxel 75 mg/m\^2 and cisplatin 75 mg/m\^2, respectively, 43°C, 90min.” NCT03373058 ↗

“Docetaxel 75 mg/m2 IV day 1, Doxorubicin 50 mg/m2 IV day 1, Cyclophosphamide 500 mg/m2 IV day 1” NCT01501487 ↗

“Docetaxel, which will be given into a vein for 60 minutes on the first day of each 21-day cycle” NCT00942578 ↗

“Squamous carcinoma: docetaxel 60 mg/m2, d1 + cisplatin 25 mg/m2, d1-3 or carboplatin AUC=4-6 d1” NCT05472467 ↗

“QL1706：5mg/kg，iv，d1 combined with Gemcitabine (1000mg/m2，iv，d1、d8 )or DOCETAXEL (60mg/m2，iv，d1)” NCT07330596 ↗

“HIPEC: perfusion with oxaliplatin (460mg/m2 ) (42 °C) followed by docetaxel (50mg/m2 ) (37°C)” NCT03348150 ↗

“docetaxel 50 mg/m2, oxaliplatin 85 mg/m2, leucovorin 200 mg/m2 and 5-fluorouracil 2600 mg/m2” NCT04597294 ↗

“Patients received docetaxel administered at a dose of 75 mg/m(2) every 3 weeks for 4 cycles.” PMID 23740935 ↗ Jun 2013

“(Note: Gemcitabine can be replaced by docetaxel, albumin-bound paclitaxel, paclitaxel, etc.)” NCT07328854 ↗

“Taxotere (Docetaxel) is an FDA approved chemotherapy drug to treat certain forms of cancer.” NCT00215345 ↗

“The experimental group received 4-course chemotherapy of docetaxel combined with nedaplatin” NCT04174079 ↗

“chemotherapy：Docetaxel 60-75 mg/m2 d1, administrated for 2-4 cycles, 3 weeks for one cycle” NCT06208033 ↗

“Docetaxel 75mg/m2 intravenous d1, cisplatin 75mg/m2 intravenous d1,repeated every 3 weeks.” NCT01069081 ↗

“Docetaxel (30 mg/m2), Oxaliplatin (70 mg/m2) and S1 (60 mg/2) will be given every 2 weeks.” NCT01928524 ↗

“Docetaxel 35 mg/m² IV on Days 1 and 8 of each 21-day cycle (administered over 60 minutes)” NCT07547592 ↗

“Combination of cisplatin and docetaxel administered as two cycles given every three weeks” NCT00460551 ↗

“Bevacizumab was combined with docetaxel in 90% of Chinese patients and paclitaxel in 10%.” PMID 22490570 ↗ Mar 2012

“Weekly docetaxel (25mg/㎡) and nedaplatin (25mg/㎡) concurrent with thoracic radiotherapy” NCT03673657 ↗

“Docetaxel on Day 1 of 21-day cycles OR Paclitaxel on Days 1, 8, and 15 of 28-day cycles” NCT02651610 ↗

“pemetrexed + carbo/cis or paclitaxel + carbo or docetaxel + carbo/cis for non squamous” NCT06003075 ↗

“cisplatin or carboplatin plus docetaxel, paclitaxel, or gemcitabine for squamous NSCLC” NCT05583188 ↗

“Investigator's choice of docetaxel or paclitaxel administered by intravenous infusion” NCT04784715 ↗

“the active ingredient of Hospira Docetaxel Injection is the same as that of Taxotere®” NCT01268163 ↗

“Toripalimab 240mg, d1; docetaxel 75mg/m2 d1; cisplatin 75mg/m2 d1, q21d, for 2 cycles” NCT04296747 ↗

“Prior to surgery: trastuzumab, HS627, and docetaxel for 4 cycles (1 cycle = 21 days).” NCT04514419 ↗

“SOC group: Second-line systemic therapy is based on docetaxel or albumin-paclitaxel.” NCT06523673 ↗

“patients allergic to carboplatinum will receive docetaxel 75 mg/m2/1 hour infusion” NCT01867086 ↗

“Could be paclitaxel, docetaxel or Nab-paclitaxel, according to physician's choice.” NCT07317778 ↗

“Tislelizumab 200 mg, docetaxel 50 mg m-2 and oxaliplatin 100 mg m-2 intravenously” NCT06469060 ↗

“in combination with Docetaxel 75mg/m2,intravenous infusion，at day1 every 3 weeks” NCT04582955 ↗

“Docetaxel 75 mg/m2 will be administered in the several days after leukapheresis.” NCT00850785 ↗

“weekly docetaxel(25mg/㎡) and nedaplatin(25mg/㎡) concurrent with chest radiation” NCT03006575 ↗

“On Cycle 1 Day 15, patients receive docetaxel (75 mg/m2), cisplatin (75 mg/m2).” NCT00130780 ↗

“weekly docetaxel(25mg/㎡) and nedaplatin(25mg/㎡) concurrent with chest radiation” NCT03661567 ↗

“Docetaxel is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug” NCT04878107 ↗

“Chemotherapy with platinum-based double drugs(Pemetrexed,Gemcitabine,Docetaxel)” NCT03758677 ↗

“weekly docetaxel(25mg/㎡) and nedaplatin(25mg/㎡) concurrent with chest radiation” NCT03905317 ↗

“weekly docetaxel(25mg/㎡) and nedaplatin(25mg/㎡) concurrent with chest radiation” NCT03904563 ↗

“Taxanes are paclitaxel or docetaxel, and platinum is carboplatin or cisplatin.” NCT03393507 ↗

“Docetaxel (75 mg/m2) IV plus carboplatin (AUC 5) IV every 3 weeks for 4 cycles” NCT02441933 ↗

“weekly topotecan 3.5 mg/m(2) and docetaxel 30 mg/m(2) for 3 consecutive weeks” PMID 19307014 ↗ Jun 2009

“docetaxel was given 75 mg/m\^2 i.v. on day 1 ,each 21-day cycle for 2 cycles.” NCT04181372 ↗

“Modified-FOLFOX-6 or FLOT (Fluorouracil, Leucovorin, Oxaliplatin, Docetaxel)” NCT07603375 ↗

“docetaxel (T) 75 mg/m2, cisplatin (P) 75 mg/m2 through intravenous infusion” NCT05798793 ↗

“Chemotherapy, Docetaxel （25mg/m2）+Cisplatin (25mg/m2) 1st/8th/15th/22nd day” NCT03708042 ↗

“Docetaxel: 60-75 mg/m2 every 3 weeks, administered on day 1 of each cycle.” NCT05192681 ↗

“Under continuous ADT, docetaxel 75mg/m\^2 body surface area every 21 days” NCT06306612 ↗

“Tau- topo II+ ERCC1+ : Docetaxel 70 mg/m2 / Epirubicin 90 mg/m2 on day 1.” NCT00776724 ↗

“weekly infusion of docetaxel (25mg/m2) and cisplatin (25mg/m2) during RT” NCT04951063 ↗

“Chemotherapy with Docetaxel, Oxaliplatin, and 5-Fluorouracil/ Leucovorin” NCT04028167 ↗

“oral docetaxel will be supplied in capsules and oral HM30181A-UK tablets” NCT02963168 ↗

“docetaxel, oxaliplatin, fluorouracil, and leucovorin (the FLOT regimen)” NCT06411171 ↗

“investigator-selected taxane (docetaxel, paclitaxel, or nab-paclitaxel)” PMID 41576297 ↗ Jan 2026

“Docetaxel 75 mg/m2 IV over 1 hour on Day 1 followed by cyclophosphamide” NCT00493870 ↗

“Docetaxel,75mg/m2, intravenous, on day 1 of each 21 day cycle, 4 cycles” NCT02539017 ↗

“treatment with oral Xeloda plus intravenous (iv) Taxotere (docetaxel).” NCT00127933 ↗

“Cisplatin, pemetrexed, gemcitabine, carboplatin, paclitaxel, docetaxel” NCT06623656 ↗

“Doxorubin 60mg/㎡ d1 or Epirubicin 75mg/㎡ d1 Docetaxel 75mg/㎡ d1 1/21d” NCT04499118 ↗

“Docetaxel, intravenous, 75 mg/M2, day 2, every 21 days, 3 to 6 cycles” NCT01275183 ↗

“Chemotherapeutic agents are limited to irinotecan or docetaxel alone.” NCT03547804 ↗

“Patients receive Neoadjuvant Docetaxel (75mg/m2 on day1 03:30-04:30)” NCT03574324 ↗

“e.g., paclitaxel 80 mg/m² weekly or docetaxel 75-100 mg/m² triweekly” NCT06970912 ↗

“Docetaxel concentrated for solution for infusion (IV administration)” NCT06967987 ↗

“Followed by a taxane; paclitaxel = 175 mg/m2 or docetaxel = 75 mg/m2” NCT00140075 ↗

“three cycles of neoadjuvant chemotherapy (cisplatin with docetaxel)” PMID 19604722 ↗ Jul 2009

“Docetaxel plus cisplatin is one of options of front line treatment.” NCT00270582 ↗

“Docetaxel 65 mg/m2 and Oxaliplatin 100 mg/m2 on day 1 every 3 weeks” NCT01888978 ↗

“docetaxel 75mg/m2 d1 plus DDP 75mg/m2 d1 for 3 cycles every 21days” NCT05232552 ↗

“Placebo 7.5 and Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)” NCT00203372 ↗

“Regimen 2: docetaxel 75mg/m2 d1 + cisplatin 75 mg/m2 day1/ day1-2.” NCT02883543 ↗

“two cycles of Docetaxel 60mg per square meter of body-surface area” NCT03734952 ↗

“followed by weekly paclitaxel, dose-dense paclitaxel or docetaxel” NCT06186700 ↗

“Docetaxel 60-75mg/m2, 4 cycles; or pemetrexed 500mg/m2, 4 cycles.” NCT01707329 ↗

“Docetaxel: 60-75 mg/m2, D1, Q3W,for 4-6 cycles，intravenous drip.” NCT06618391 ↗

“T: Taxanes, including docetaxel, nab-paclitaxel, and paclitaxel.” NCT07378306 ↗

“Drug: Docetaxel Docetaxel 100 mg/m2 every 21 days for 4 cycles.” NCT01472146 ↗

“Either docetaxel 75 mg/m² or paclitaxel 135-175 mg/m² on day 1” NCT07546383 ↗

“Docetaxel (Taxotere) 100 mg/m2 is to be administered on day 1.” NCT00206466 ↗

“Docetaxel (Taxotere) 100 mg/m2 is to be administered on day 1.” NCT00206453 ↗

“Docetaxel: 75 mg/m2, administered by IV infusion every 3 weeks” NCT04760431 ↗

“docetaxel 50 mg/m2 intravenous infusion on day 1 every 2 weeks” NCT06253650 ↗

“followed by cycles of T (4 cycles docetaxel 100 mg/m² 3-weekly” NCT03283384 ↗

“including docetaxel (75 mg/m\^2 by IV on Day 1, every 21 days)” NCT07526792 ↗

“docetaxel 75mg/m\^2, or nab-paclitaxel 260mg/m\^2, IV, days 1” NCT05114720 ↗

“Paclitaxel (80 mg/m2 weekly or Docetaxel 75 mg/m2 day 1 q 22)” NCT01200212 ↗

“docetaxel (escalating doses: 25,30,35,40 mg/m2,day1 and day8)” NCT00915850 ↗

“Docetaxel (75 mg/m2 Q3W on Day 1) concurrent with trastuzumab” NCT06548178 ↗

“Her-2 Negative patients with DOS Docetaxel： 60 mg/m2, iv, d1” NCT02725424 ↗

“Docetaxel 75 mg/m2 + Carboplatin AUC(area under the curve)=6” NCT01054482 ↗

“[Docetaxel 75mg/m2 + Nimotuzumab 400mg + Pucotenlimab 200mg]” NCT07354984 ↗

“NSCLC and BRC patients receive docetaxel (75mg/m2) treatment” NCT01891123 ↗

“BIND-014 (Docetaxel Nanoparticles for Injectable Suspension)” NCT01792479 ↗

“BIND-014, a PSMA-directed docetaxel-containing nanoparticle” PMID 29978216 ↗ Oct 2018

“Docetaxel (DTX) has demonstrated activity in HNSCC and SGC.” NCT07667400 ↗

“Pertuzumab + Trastuzumab + Taxane (docetaxel or paclitaxel)” NCT06135714 ↗

“Name/Substance: Docetaxel Formulation: Liquid (20 mg/2 ml)” NCT01434394 ↗

“Docetaxel: 60 mg/m\^2 intravenous infusion for 60 minutes” NCT05050760 ↗

“PIPAC Intraperitoneal chemotherapy for PIPAC is Docetaxel” NCT04410887 ↗

“Cisplatin, Carboplatin, Docetaxel, Paclitaxel, Pemetrexed” NCT02064491 ↗

“Chemotherapy list: * Liposomal Doxorubicin; * Docetaxel;” NCT03632798 ↗

“Docetaxel at a dose of 50 mg/m² iv over one hour (day 1)” NCT03647969 ↗

“Docetaxel 75 mg/m² IV infusion at hospital every 21 days” NCT01564056 ↗

“Docetaxel 100 mg/m2 every 3 weeks in the comparator arm” NCT00393939 ↗

“Docetaxel (TAXOTERE®) will be administered at 75 mg/m2.” NCT01796028 ↗

“sequential Docetaxel 100 mg/m 2, IVGtt, D1 Q3w, 4 cycle” NCT05400993 ↗

“Other chemotherapy drugs,such as Docetaxel, gemcitabine” NCT03489616 ↗

“docetaxel:75mg/m2 cisplatin：75 mg/m2 5-Fu：750 mg/m2/day” NCT02290145 ↗

“Docetaxel: 75mg/m2，intravenous(iv), every 3 weeks(q3w)” NCT06254690 ↗

“docetaxel plus cisplatin were used weekly in both arms” NCT01937208 ↗

“Docetaxel: 75mg/m2，intravenous(iv), every 3 weeks(q3w)” NCT06770296 ↗

“Docetaxel 75 mg/m\^2 on D1+cisplatin 75 mg/m\^2 on D1” NCT00820755 ↗

“cisplatin or carboplatin plus docetaxel or paclitaxel” NCT03529279 ↗

“Docetaxel: 75 mg/m², intravenous infusion over 1 hour” NCT07581795 ↗

“ModraDoc006 is a novel oral formulation of docetaxel.” PMID 33744986 ↗ Mar 2021

“* Docetaxel 100 mg/m\^2, 2-3 hour infusion on day 8.” NCT01696669 ↗

“Chemotherapy Regimen 2：Docetaxel 75 mg/m\^2 on Day 1” NCT01665417 ↗

“FLOT Regimen: 5-fluorouracil, Oxaliplatin, Docetaxel” NCT01206218 ↗

“Docetaxel (Taxotere®) 85 mg/m2 1 hour iv infusion d1” NCT00030771 ↗

“docetaxel (Taxotere) 75-100 mg/m\^2 IV every 3 weeks” NCT00281697 ↗

“docetaxel : 75 mg/m2 or paclitaxel 175 mg/m2, day 1” NCT01150513 ↗

“docetaxel, carboplatin, trastuzumab, and pertuzumab” NCT07239271 ↗

“CB-839 in combination with standard dose docetaxel” NCT02071862 ↗

“Epirubicin/Cyclophosphamide Followed by Docetaxel” NCT03507465 ↗

“i. Docetaxel or ii. Irinotecan or iii. Paclitaxel” NCT06190782 ↗

“Regimen C: Docetaxel 75 mg/m2, Cisplatin 75 mg/m2” NCT00070629 ↗

“taxane (paclitaxel, nab-paclitaxel or docetaxel” NCT05172518 ↗

“Drug:Docetaxel 60-75 mg/m\^2 by IV infusion Q3W” NCT04158440 ↗

“TPF ( docetaxel, cisplatin and 5-fluorouracil )” NCT02944708 ↗

“* Docetaxel (75mg/m2, intravenous(IV)) Day(D)1” NCT03881878 ↗

“docetaxel, cetuximab, methotrexate, paclitaxel” NCT03769506 ↗

“Drug: Docetaxel Q3W Administered intravenously” NCT07387081 ↗

“Docetaxel +Carboplatin+Trastuzumab+Pertuzumab+” NCT07294534 ↗

“Docetaxel 50 mg/m2 is given as 1 hour infusion” NCT06978062 ↗

“DL 1: Docetaxel 60mg/m\^2, Temsirolimus 15mg.” NCT01206036 ↗

“Docetaxel-prednisolone (TAX327 regimen) alone” NCT01487902 ↗

“docetaxel: 75 mg/m2, i.v., 1 hour, once daily” NCT00765011 ↗

“Taxane (Paclitaxel or Docetaxel) IV infusion.” NCT00849667 ↗

“Docetaxel only is administered every 3 weeks.” NCT00678626 ↗

“Docetaxel 75 mg/m² as a 1 hour i.v. infusion” NCT00544765 ↗

“Drug: Docetaxel Dose: 75mg/m2 Other Name: FA” NCT05171530 ↗

“Docetaxel (75 mg/m2 IV over 60 min on day 1)” NCT00011414 ↗

“docetaxel/carboplatin/trastuzumab/Pertuzumab” NCT04094896 ↗

“docetaxel 50 mg/m2 IV over 1 hour at 1st day” NCT01672333 ↗

“Docetaxel#50mg/m2d1,iv infusion for 1 hour#” NCT04341857 ↗

“TP (docetaxel 75 mg/m²; cisplatin 75 mg/m²)” NCT05860868 ↗

“4 cycles FEC followed by 4 cycles docetaxel” NCT01180335 ↗

“Experimental group:docetaxel,cisplatin,5-FU” NCT03196869 ↗

“TP (docetaxel 75 mg/m²; cisplatin 75 mg/m²)” NCT05062005 ↗

“Docetaxel(100mg/m2 d1 iv Q3W for 4 Cycles )” NCT04290793 ↗

“75mg/m\^2 docetaxel by intravenous infusion” NCT06196736 ↗

“chemotherapy using Docetaxel 75mg/m2 IV D1” NCT03890185 ↗

“Docetaxel 100 mg/m² body surface area i.v.” NCT00847444 ↗

“Docetaxel 75 mg/m² body surface area i.v.” NCT00670878 ↗

“3. Docetaxel - 75-100 mg/m2 every 3 weeks” NCT00246571 ↗

“Docetaxel 70mg/m2BSA, q 3 weeks, 8 cycles” NCT01461759 ↗

“Docetaxel: 100mg/m2 IV drip every 21 days” NCT06656624 ↗

“Docetaxel 75mg/m2BAS, q 3 weeks, 3 cycles” NCT01462149 ↗

“Docetaxel 100mg per square meter, d1 q3w” NCT07393425 ↗

“nab-paclitaxel, pemetrexed, or docetaxel” NCT07139041 ↗

“docetaxel and trastuzumab and pertuzumab” NCT04750122 ↗

“Docetaxel 25mg/m2 + Cisplatin 25mg/m2 QW” NCT05481775 ↗

“Docetaxel \[30 mg/m2, day 1 and day 8\]” NCT01248299 ↗

“* Docetaxel 50 mg/m², d1, d15, d29, d43” NCT02581462 ↗

“Using 5-FU, Oxaliplatin, and Docetaxel” NCT04699994 ↗

“polysorbate 80, ethanol free docetaxel” NCT05207514 ↗

“Docetaxel 50mg/m2 iv day 1 over 1 hour” NCT03399071 ↗

“Drug: Docetaxel, 75mg/m2, Q3W, C1C2C3.” NCT07645846 ↗

“Docetaxel 75mg/m2 +Nedaplatin 75mg/m2” NCT01137123 ↗

“docetaxel 40mg/m2, IV, q3weeks, Day 1” NCT05311189 ↗

“Apatinib 500mg with Docetaxel 60mg/m2” NCT03334591 ↗

“Docetaxel or comparable generic brand” NCT07217301 ↗

“docetaxel, cisplatin and capecitabine” NCT02915965 ↗

“Docetaxel (HHT) 2.5mg/㎡/day, days 3-7” NCT05893472 ↗

“Docetaxel+Irinotecan+5-FU+LV (1 pat.)” NCT01379482 ↗

“Docetaxel every 3 weeks for 2 cycles” NCT00153881 ↗

“Docetaxel: 100mg/m2 IV every 21 days” NCT06375707 ↗

“Docetaxel 75mg/m2 IV (every 3 weeks)” NCT04220398 ↗

“Docetaxel 50 mg/m² IV infusion on D1” NCT04736485 ↗

“Docetaxel (TXT) + Gemcitabine (GEM)” NCT03121833 ↗

“KN026 in Combination With Docetaxel” NCT04881929 ↗

“Decitabine, Docetaxel, Doxorubicin” NCT02788201 ↗

“docetaxel(75mg/m2, d1, q3w, ivgtt)” NCT06230055 ↗

“Docetaxel 75mg/m2/dose IV on Day 8” NCT05634369 ↗

“Docetaxel/prednisone + afuresertib” NCT04060394 ↗

“1. TAC:Docetaxel 75 mg/㎡ iv day 1” NCT01917578 ↗

“Pertuzumab+ Trastuzumab+Docetaxel” NCT07294508 ↗

“Docetaxel 75 mg/m2, every 3 weeks” NCT02001506 ↗

“docetaxel 100 mg/m2 i.v. infusion” NCT00256360 ↗

“Docetaxel: 80-100mg/m2,d1,q3w\*4” NCT02455141 ↗

“Docetaxel 75mg/m2, 3w, 2cycles.” NCT04009265 ↗

“docetaxel + carboplatin regimen” NCT05475678 ↗

“Taxanes (Paclitaxel, Docetaxel)” NCT02299999 ↗

“Docetaxel 75mg/m2 IVF for 1hour” NCT01283204 ↗

“Docetaxel 50 mg/m2 IV on Day 1” NCT05733689 ↗

“docetaxel (start dose 75mg/m2)” NCT00798070 ↗

“docetaxel (60mg/m² per cycle)” NCT07591467 ↗

“docetaxel given every 3 weeks” NCT05074290 ↗

“i.v. docetaxel 75 or 60 mg/m2” NCT00663832 ↗

“Docetaxel 50mg/M2 intravenous” NCT04384601 ↗

“docetaxel 70-75 mg/m2， 30min” NCT04733820 ↗

“Docetaxel 75-100 mg/m\^2 IV” NCT00262067 ↗

“Docetaxel (40 mg/m², day 1)” NCT06207981 ↗

“docetaxel 70mg/m2，iv，d1，Q3W” NCT06463834 ↗

“Docetaxel 40 mg/m2 iv day 1” NCT05527782 ↗

“Docetaxel 75 mg / m2 at D1” NCT02216617 ↗

“TP (cisplatin + docetaxel)” NCT06895369 ↗

“Docetaxel (75mg/m2 IV d1)” NCT03589950 ↗

“Docetaxel 75mg/m2 iv day1” NCT03055312 ↗

“docetaxel and carboplatin” NCT04836156 ↗

“Docetaxel 75mg/m2，iv，d1” NCT03359694 ↗

“Drug:Docetaxel 60-75 mg” NCT06437977 ↗

“Docetaxel: 60-75 mg/m²” NCT07358689 ↗

“Docetaxel 75 mg/m2 d 1” NCT01181401 ↗

“Docetaxel 75 mg/m² D1” NCT00535275 ↗

“Docetaxel 40mg/m2, d3” NCT05648487 ↗

“Taxotere (Docetaxel)” NCT01172028 ↗

“Taxotere (docetaxel)” NCT00031187 ↗

“docetaxel + platinum” NCT00391586 ↗

“Docetaxel (Taxotere)” NCT00251329 ↗

“Docetaxel (Taxotere)” NCT01746277 ↗

“Docetaxel (Taxotere)” NCT00659269 ↗

“Docetaxel 75mg/m2 d1” NCT02769104 ↗

“docetaxel (75 mg/m²)” NCT05430906 ↗

“- Docetaxel 50 mg/m²” NCT02128243 ↗

“Docetaxel 75mg/m2 IV” NCT03083808 ↗

“Docetaxel75mg/m2 D1” NCT02621333 ↗

“docetaxel, 4 cycles” NCT01206881 ↗

“Docetaxel Injection” NCT04400695 ↗

“Docetaxel 75 mg/m²” NCT01368848 ↗

“Device: Docetaxel” NCT00911820 ↗

“docetaxel (75 mg” NCT07230626 ↗

“Drug: Docetaxel” NCT05116800 ↗

“Drug: Docetaxel” NCT02511132 ↗

“Drug: Docetaxel” NCT00008411 ↗

“Drug: Docetaxel” NCT04034823 ↗

“Drug: Docetaxel” NCT06470633 ↗

“Drug: Docetaxel” NCT00090610 ↗

“or docetaxel” NCT04876651 ↗

“docetaxel” NCT00324012 ↗

“Docetaxel” NCT01703910 ↗

“Docetaxel” NCT06496178 ↗

NCT04144582 ↗

NCT00065182 ↗

NCT06009627 ↗

NCT00321646 ↗

NCT00357747 ↗

NCT04343885 ↗

NCT03932266 ↗

NCT03015727 ↗

NCT05169684 ↗

NCT01186731 ↗

NCT00321698 ↗

NCT00528866 ↗

NCT00568971 ↗

NCT01138163 ↗

NCT02578368 ↗

NCT00439270 ↗

NCT01917279 ↗

NCT00511446 ↗

NCT06738251 ↗

NCT00076024 ↗

NCT00543829 ↗

NCT03756064 ↗

NCT00003231 ↗

NCT05020457 ↗

NCT02508246 ↗

NCT01588431 ↗

NCT00294385 ↗

NCT07545044 ↗

NCT02777788 ↗

NCT01149902 ↗

NCT00625898 ↗

NCT01485926 ↗

NCT00718913 ↗

NCT00209092 ↗

NCT04957212 ↗

NCT00511576 ↗

NCT03837977 ↗

NCT06618014 ↗

NCT00114816 ↗

NCT00310154 ↗

NCT05382559 ↗

NCT00684099 ↗

NCT00697437 ↗

NCT02664935 ↗

NCT03837353 ↗

NCT07603856 ↗

NCT03017404 ↗

NCT01633541 ↗

NCT05543629 ↗

NCT00625937 ↗

NCT00096304 ↗

NCT03933449 ↗

NCT01137994 ↗

NCT00424606 ↗

NCT02009449 ↗

NCT01935778 ↗

NCT06879717 ↗

NCT04025879 ↗

NCT02099175 ↗

NCT05929768 ↗

NCT00569673 ↗

NCT02627248 ↗

NCT00024167 ↗

NCT01547741 ↗

NCT01253642 ↗

NCT01754623 ↗

NCT02900742 ↗

NCT05116189 ↗

NCT04595929 ↗

NCT00022022 ↗

NCT00310089 ↗

NCT00277043 ↗

NCT02057107 ↗

NCT04136782 ↗

NCT00309985 ↗

NCT02099188 ↗

NCT04340882 ↗